Related Experiment Video

Updated: May 15, 2026

Identification and Isolation of Burst-Forming Unit and Colony-Forming Unit Erythroid Progenitors from Mouse Tissue by Flow Cytometry
08:31

Identification and Isolation of Burst-Forming Unit and Colony-Forming Unit Erythroid Progenitors from Mouse Tissue by Flow Cytometry

Published on: November 4, 2022

Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic

Julia Hartmann1, Friederike Braulke, Ursula Sinzig

  • 1Department of Hematology and Oncology, Georg August University, Göttingen, Germany.

Leukemia Research
|December 25, 2012
PubMed

Insights

Iron overload in myelodysplastic syndromes (MDS) impairs erythroid progenitor cell growth. This effect is seen even with mild iron elevation and is reversible with iron chelation therapy, improving patient outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Iron Metabolism

Background:

  • Iron overload is a significant comorbidity in myelodysplastic syndromes (MDS), particularly in low-risk patients receiving frequent red blood cell transfusions.
  • Accumulated iron can negatively impact hematopoietic stem cell function and contribute to disease progression.

Purpose of the Study:

  • To investigate the impact of iron overload on hematopoietic progenitor cell proliferation in MDS patients.
  • To compare the effects of iron overload on erythroid versus myeloid progenitor cells.
  • To assess the reversibility of iron overload-induced suppression by iron chelation therapy.

Main Methods:

  • Colony formation assays were performed on hematopoietic cells from MDS patients with and without iron overload.
  • Patient samples were stratified based on serum ferritin levels.
  • Functional assays assessed the proliferation capacity of erythroid progenitors (BFU-E) and myeloid progenitors (CFU-GM).

Main Results:

  • Iron overload significantly suppresses the proliferation of erythroid progenitor cells (BFU-E) in MDS patients.
  • The myeloid progenitor compartment (CFU-GM) showed no significant impact from iron overload.
  • Impaired BFU-E proliferation was observed even in patients with slightly elevated ferritin levels compared to those with normal levels.
  • The suppressive effect of iron overload on BFU-E was reversible following iron chelation therapy.

Conclusions:

  • Iron overload detrimentally affects erythroid progenitor cell function in MDS patients.
  • Early detection and management of iron overload are crucial for mitigating its negative impact on hematopoiesis.
  • Iron chelation therapy offers a potential therapeutic strategy to reverse iron-induced suppression and improve outcomes in MDS.

More Related Videos

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...